Vellum Health, a mobile healthcare platform delivering advanced intravenous (IV) services at the bedside, announced the closing of its Series A funding round. The funding round was led by FCA Venture Partners, with participation from Green Park & Golf Ventures, and followed by additional investment from seed round angel investors.
The company is also announcing the launch of its new brand called Vellum Health, which unifies a portfolio of acquired vascular access companies into a single, tech-enabled care delivery platform.
Vellum Health offers mobile IV access, infusion therapy, and on-site transfusion services to patients in skilled nursing facilities, long-term acute care centers, and homes. And by enabling hospitals, payors, and post-acute providers to extend high-quality care into lower-cost, more convenient settings, Vellum reduces unnecessary hospitalizations and improves patient outcomes.
With this funding round, Vellum Health will accelerate its expansion into new markets and further invest in its proprietary AI-powered technology platform. And this platform enables secure EMR integration, intelligent care navigation, dynamic documentation, and proactive patient identification—serving as the connective tissue between providers, payors, and clinical teams.
Vellum Health currently serves facilities and home-based patients across multiple states, partnering with payors, hospitals, and post-acute care providers to extend access to complex care without requiring hospitalization.
KEY QUOTES:
“This funding marks a pivotal milestone for our company. It allows us to scale nationally while launching a brand that represents our commitment to smarter, value-driven care. Our model delivers expert care directly to the bedside—anytime, anywhere.”
Tyler Payne, CEO of Vellum Health
“Vellum is solving real operational and clinical challenges with a patient-centered, mobile-first model. We’re excited to support their growth and believe their model is uniquely positioned to meet the needs of an evolving healthcare landscape.”
Matt King, Managing Partner at FCA Venture Partners
“Our team of early investors saw something powerful in Vellum’s vision from the very beginning. We’re proud to continue supporting this next phase of growth as Vellum transforms how and where care is delivered. Their ability to combine technology, clinical quality, and operational excellence is exactly what modern healthcare needs.”
Michael Sanderson, a seed round investor
